| Literature DB >> 26724463 |
Valerie A McCormack1, Anya Burton2, Isabel dos-Santos-Silva3, John H Hipwell4, Caroline Dickens5, Dorria Salem6, Rasha Kamal7, Mikael Hartman8, Charmaine Pei Ling Lee9, Kee-Seng Chia10, Vahit Ozmen11, Mustafa Erkin Aribal11, Anath Arzee Flugelman12, Martín Lajous13, Ruy Lopez-Riduara14, Megan Rice15, Isabelle Romieu16, Giske Ursin17, Samera Qureshi18, Huiyan Ma19, Eunjung Lee20, Carla H van Gils21, Johanna O P Wanders21, Sudhir Vinayak22, Rose Ndumia22, Steve Allen23, Sarah Vinnicombe24, Sue Moss25, Jong Won Lee26, Jisun Kim26, Ana Pereira27, Maria Luisa Garmendia27, Reza Sirous28, Mehri Sirous28, Beata Peplonska29, Agnieszka Bukowska29, Rulla M Tamimi15, Kimberly Bertrand30, Chisato Nagata31, Ava Kwong32, Celine Vachon33, Christopher Scott33, Beatriz Perez-Gomez34, Marina Pollan34, Gertraud Maskarinec35, Graham Giles36, John Hopper37, Jennifer Stone38, Nadia Rajaram39, Soo-Hwang Teo40, Shivaani Mariapun39, Martin J Yaffe41, Joachim Schüz2, Anna M Chiarelli42, Linda Linton43, Norman F Boyd43.
Abstract
Mammographic density (MD) is a quantitative trait, measurable in all women, and is among the strongest markers of breast cancer risk. The population-based epidemiology of MD has revealed genetic, lifestyle and societal/environmental determinants, but studies have largely been conducted in women with similar westernized lifestyles living in countries with high breast cancer incidence rates. To benefit from the heterogeneity in risk factors and their combinations worldwide, we created an International Consortium on Mammographic Density (ICMD) to pool individual-level epidemiological and MD data from general population studies worldwide. ICMD aims to characterize determinants of MD more precisely, and to evaluate whether they are consistent across populations worldwide. We included 11755 women, from 27 studies in 22 countries, on whom individual-level risk factor data were pooled and original mammographic images were re-read for ICMD to obtain standardized comparable MD data. In the present article, we present (i) the rationale for this consortium; (ii) characteristics of the studies and women included; and (iii) study methodology to obtain comparable MD data from original re-read films. We also highlight the risk factor heterogeneity captured by such an effort and, thus, the unique insight the pooled study promises to offer through wider exposure ranges, different confounding structures and enhanced power for sub-group analyses.Entities:
Keywords: Breast cancer; International Consortium; Mammographic density
Mesh:
Year: 2015 PMID: 26724463 PMCID: PMC4738079 DOI: 10.1016/j.canep.2015.11.015
Source DB: PubMed Journal: Cancer Epidemiol ISSN: 1877-7821 Impact factor: 2.984